Presentación    
GROUP 15.
VASCULAR PHYSIOLOGY AND PHARMACOLOGY
Composition
Name
Position
Institution
Mercedes Salaíces Sánchez
Catedrática. Departamento de Farmacología. Facultad de Medicina
Universidad Autónoma de Madrid
Andrea Aguado Martínez
Investigador Predoctoral
Universidad Autónoma de Madrid
María Jesús Alonso Gordo
Profesora Titular. Departamento de Bioquímica, Fisiología y Genética Molecular
Universidad Rey Juan Carlos
María Soledad Avendaño Herrado
Investigador Predoctoral
Universidad Autónoma de Madrid
Gloria Balfagón Calvo
Catedrática. Departamento de Fisiología. Facultad de Medicina
Universidad Autónoma de Madrid
Javier Blanco Rivero
Profesor Contratado Doctor. Departamento de Fisiología. Facultad de Medicina
Universidad Autónoma de Madrid
Ana María Briones Alonso
Investigadora
Universidad Autónoma de Madrid
Ana Belén García Redondo
Investigadora
Universidad Autónoma de Madrid
Raquel Hernanz Martín
Profesor Contratado Doctor, Departamento de Bioquímica, Fisiología y Genética Molecular
Universidad Rey Juan Carlos
Ángela Martín Cortes
Investigadora
Universidad Rey Juan Carlos
Marta Miguel Castro
Investigadora
Instituto de Investigación en Ciencias de la Alimentación. CSIC-UAM
Roberto Palacios Ramírez
Investigador Predoctoral
Universidad Rey Juan Carlos
José Vicente Pérez Girón
Investigador
Universidad Autónoma de Madrid
Fernanda Roberta Roque
Investigadora
Universidad Autónoma de Madrid
Esther Sastre Gil
Investigadora Predoctoral
Universidad Autónoma de Madrid
Laura Caracuel Cano
InvestigadoraPosdoctoral
Universidad Autónoma de Madrid
Summary
Our group is a well-established research group with more than 30 years of experience in the study of the mechanisms involved in the functional, structural and mechanical alterations of the vasculature in various cardiovascular pathologies such as ageing, diabetes and, in particular, hypertension.
The group is located at the Faculty of Medicine (UAM) and maintains research collaborations with investigators at various universities in Spain and in other countries. Our main objective is to gain further insight into the physiological and molecular mechanisms involved in alterations of resistance and conductance arteries in cardiovascular pathologies. To conduct our research, we generally use various experimental approaches including in vivo animal models, ex vivo experiments and in vitro cell-based studies combined with physiological, pharmacological and molecular biology techniques. In addition, we have begun to translate this knowledge into human studies. In terms of the mediators involved, we have a particular interest in the role of prostanoids derived from the inducible isoform of cyclooxygenase (COX-2) and reactive oxygen species (and their interaction among each other or with other mediators
such as nitric oxide) in inflammatory conditions that resemble those found in cardiovascular pathologies. This research is important given the essential role these mediators play in the control of vascular smooth muscle tone and vascular structure.
Lines of research
• Oxidative stress, COX-derived products and vascular function and remodelling. Changes with hypertension and other cardiovascular pathologies.
• Neural control of vascular tone.
• Cardiovascular effects of heavy metals.
• Adipose tissue and vascular alterations in cardiovascular pathologies.